1. Home
  2. GBBK vs THTX Comparison

GBBK vs THTX Comparison

Compare GBBK & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBBK
  • THTX
  • Stock Information
  • Founded
  • GBBK 2021
  • THTX 1993
  • Country
  • GBBK United States
  • THTX Canada
  • Employees
  • GBBK N/A
  • THTX N/A
  • Industry
  • GBBK Blank Checks
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GBBK Finance
  • THTX Health Care
  • Exchange
  • GBBK Nasdaq
  • THTX Nasdaq
  • Market Cap
  • GBBK 61.4M
  • THTX 56.1M
  • IPO Year
  • GBBK 2022
  • THTX N/A
  • Fundamental
  • Price
  • GBBK $11.10
  • THTX $1.21
  • Analyst Decision
  • GBBK
  • THTX Hold
  • Analyst Count
  • GBBK 0
  • THTX 1
  • Target Price
  • GBBK N/A
  • THTX N/A
  • AVG Volume (30 Days)
  • GBBK 20.3K
  • THTX 31.8K
  • Earning Date
  • GBBK 01-01-0001
  • THTX 10-10-2024
  • Dividend Yield
  • GBBK N/A
  • THTX N/A
  • EPS Growth
  • GBBK N/A
  • THTX N/A
  • EPS
  • GBBK 0.04
  • THTX N/A
  • Revenue
  • GBBK N/A
  • THTX $84,316,000.00
  • Revenue This Year
  • GBBK N/A
  • THTX $5.60
  • Revenue Next Year
  • GBBK N/A
  • THTX $4.62
  • P/E Ratio
  • GBBK $276.70
  • THTX N/A
  • Revenue Growth
  • GBBK N/A
  • THTX 5.75
  • 52 Week Low
  • GBBK $10.51
  • THTX $1.08
  • 52 Week High
  • GBBK $12.00
  • THTX $2.58
  • Technical
  • Relative Strength Index (RSI)
  • GBBK 54.33
  • THTX 43.96
  • Support Level
  • GBBK $11.03
  • THTX $1.21
  • Resistance Level
  • GBBK $11.15
  • THTX $1.47
  • Average True Range (ATR)
  • GBBK 0.04
  • THTX 0.07
  • MACD
  • GBBK 0.00
  • THTX -0.00
  • Stochastic Oscillator
  • GBBK 70.35
  • THTX 18.75

About GBBK Global Blockchain Acquisition Corp.

Global Blockchain Acquisition Corp is a blank check company.

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: